RxDoctor Payments Data

Russell Coulter, MD

Family Medicine · Sparta, ILNPI 1548227606

Payments from drug & device makers

$1,022in general payments, 2019–2025

Across 65 payments — averaging $15.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$180
  • Novo Nordisk$108
  • Amgen$105
  • Pfizer$84
  • Novartis$77
  • Sanofi-aventis U.S. LLC$56
  • plus $412 from 13 others

What the payments were for

  • Food & beverage$1,022100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,022 in reported general payments places this provider in the 70th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$66,024
Medicare patients
167
Services billed
657

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban278$72,151
JardianceEmpagliflozin152$46,438
XareltoRivaroxaban87$26,470
OzempicSemaglutide14$14,639
JanuviaSitagliptin Phosphate45$13,204
MyrbetriqMirabegron54$12,319
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$7,299
FarxigaDapagliflozin Propanediol23$6,755
TradjentaLinagliptin24$6,229
TrintellixVortioxetine Hydrobromide23$5,725
Potassium Chloride295$5,722
Atorvastatin Calcium281$5,032
Memantine Hcl ErMemantine Hcl41$4,569
ErtapenemErtapenem Sodium14$4,502
Levothyroxine Sodium303$4,200

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$84$72,151278 claims
Boehringer IngelheimJardiance, Tradjenta$23$52,667176 claims
Johnson & JohnsonXarelto$12$26,47087 claims
Novo NordiskOzempic$108$14,63914 claims
Astellas Pharma US IncMyrbetriq$45$12,31954 claims
GSKTrelegy Ellipta$42$7,29913 claims
AstraZenecaFarxiga$13$6,75523 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Sparta

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →